Kornitzer Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Kornitzer Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-175,000	Closed	-$1.58M	–	466
2016 Q1	$1.58M	Hold	175,000	–	–	0.03%	333
2015 Q4	$1.62M	Sell	175,000 -225,000	-56%	-$2.46M	0.03%	326
2015 Q3	$5.11M	Hold	400,000	–	–	0.08%	248
2015 Q2	$4.43M	Hold	400,000	–	–	0.06%	275
2015 Q1	$4.57M	Hold	400,000	–	–	0.06%	263
2014 Q4	$4.04M	Hold	400,000	–	–	0.05%	270
2014 Q3	$4.2M	Hold	400,000	–	–	0.05%	261
2014 Q2	$3.45M	Hold	400,000	–	–	0.04%	285
2014 Q1	$3.51M	Buy	400,000 +25,000	+7%	+$217K	0.04%	294
2013 Q4	$3.08M	Buy	375,000 +89,500	+31%	+$708K	0.03%	300
2013 Q3	$2.16M	Buy	285,500 +144,000	+102%	+$1.05M	0.03%	313
2013 Q2	$1.07M	Buy	+141,500	New	+$1.03M	0.01%	328

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kornitzer Capital Management's RDY Position: Q2 2016 in Review

Kornitzer Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2016, closing a stake of 175,000 shares — an estimated $1.58M sold.

Kornitzer Capital Management first reported a position in RDY in Q2 2013 and held it in 12 quarters. The position peaked at $5.11M in Q3 2015. 157 funds tracked by Wall St. Rank hold RDY as of Q2 2016.

Kornitzer Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2016 after selling out during the quarter.
Kornitzer Capital Management sold 175,000 Dr. Reddy's Laboratories shares in Q2 2016, an estimated $1.58M.
Kornitzer Capital Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 12 quarters.
Kornitzer Capital Management's Dr. Reddy's Laboratories position peaked at $5.11M in Q3 2015.
157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2016.

Based on Kornitzer Capital Management's 13F filing for Q2 2016, filed 29 Jul 2016.